Surgery

LimFlow System Demonstrates Excellent Sustained Amputation-free Survival and Wound Healing at One Year in PROMISE I U.S. Study

Retrieved on: 
Friday, November 6, 2020
General Health, Surgery, Medical devices, Health, Clinical trials, Clinical medicine, Medicine, Medical specialties, Acute pain, Surgical specialties, First aid, Injuries, Wound, Amputation

The 12-month results from the PROMISE I study show that 70 percent of patients achieved major amputation-free survival, similar to what was seen at six months, following treatment with the LimFlow System.

Key Points: 
  • The 12-month results from the PROMISE I study show that 70 percent of patients achieved major amputation-free survival, similar to what was seen at six months, following treatment with the LimFlow System.
  • The very challenging patients in the trial also had 75 percent of their wounds classified as healed or healing one year after treatment.
  • One-year outcomes demonstrate that the benefits from treatment with the LimFlow System are durable, said Dr. Clair.
  • The LimFlow System has not been approved for sale in the USA, Canada, or Japan.

North America Extra Corporeal Membrane Oxygenation (ECMO) System Markets, 2019-2020 & 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 6, 2020
Health, Surgery, Cardiology, Other Health, Intensive care medicine, Extracorporeal membrane oxygenation, Medical equipment, Membrane technology, Medicine, Health care, Health, Extracorporeal Life Support Organization

The "North America Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.
  • North American extra corporeal membrane oxygenation (ECMO) system market is expected to flourish at a CAGR of 4.85% over the estimated period 2019-2028.
  • The United States and Canada together constitute the North American extra corporeal membrane oxygenation (ECMO) system market.
  • Due to all these factors, the extra corporeal membrane oxygenation (ECMO) system market in Canada is expected to experience growth over the forecast years.

OncLive® Inducts 15 World-Renowned Oncology Legends Into the 2020 Class of Giants of Cancer Care®

Retrieved on: 
Friday, November 6, 2020
Research, Surgery, Hospitals, Other Health, Health, General Health, Other Science, Science, Oncology, OncLive®, Giants of Cancer Care®

OncLive is pleased to announce that yesterday it honored 15 remarkable cancer care pioneers during the 8th Annual Giants of Cancer Care Awards Ceremony.

Key Points: 
  • OncLive is pleased to announce that yesterday it honored 15 remarkable cancer care pioneers during the 8th Annual Giants of Cancer Care Awards Ceremony.
  • The 2020 class of Giants of Cancer Care inductees hail from locales around the globe, including Lagos, Nigeria; Amsterdam; Brussels; and Philadelphia.
  • This years class marks the eighth consecutive year that OncLive has saluted the physician-scientists who are shaping oncology practice, bringing the total number of honorees recognized through the Giants of Cancer Care program to 113.
  • Congratulations to the 2020 class of Giants of Cancer Care, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of OncLive.

Global Arthroscopy Devices Market- Featuring Arthrex Inc., B. Braun Melsungen AG, and CONMED Corp., Among Others | Technavio

Retrieved on: 
Friday, November 6, 2020
General Health, Surgery, Medical devices, Health, Physical therapy, Business process, Market analysis, Market research, Arthroscopy

The arthroscopy devices market is poised to grow by USD 1.7 billion during 2020-2024, progressing at a CAGR of about 6% during the forecast period.

Key Points: 
  • The arthroscopy devices market is poised to grow by USD 1.7 billion during 2020-2024, progressing at a CAGR of about 6% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201106005293/en/
    Technavio has announced its latest market research report titled Global Arthroscopy Devices Market 2020-2024 (Graphic: Business Wire)
    The report on the arthroscopy devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The arthroscopy devices market analysis includes the end-user segment and geographic landscapes.

Worldwide Industry for Surgical Drainage Devices to 2027 - Players Include B Braun Melsungen, Cook Medical and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, November 6, 2020
Surgery, Health, Medical devices, Actuarial science, Compound annual growth rate, Mathematical finance

The report provides revenue of the global Surgical Drainage Devices Market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year.

Key Points: 
  • The report provides revenue of the global Surgical Drainage Devices Market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year.
  • The report also provides the compound annual growth rate (CAGR) for the global Surgical Drainage Devices Market during the forecast period.
  • Furthermore, the report sheds light on the changing competitive dynamics in the Global Surgical Drainage Devices Market.
  • These indices serve as valuable tools for existing market players as well as for entities interested in entering the Global Surgical Drainage Devices Market.

Global Dental Surgical Equipment Market – Industry Trends and Forecast to 2024 | Technavio

Retrieved on: 
Friday, November 6, 2020
Surgery, Health, Dental, Surgery, Forecast

The dental surgical equipment market is poised to grow by USD 1.42 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period.

Key Points: 
  • The dental surgical equipment market is poised to grow by USD 1.42 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201106005023/en/
    Technavio has announced its latest market research report titled Global Dental Surgical Equipment Market 2020-2024 (Graphic: Business Wire)
    Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the dental surgical equipment market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • This study identifies the adoption of 3D printing technology as one of the prime reasons driving the dental surgical equipment market growth during the next few years.

Zimmer Biomet Announces Preliminary Results from mymobility® Clinical Study at 2020 AAHKS Annual Meeting

Retrieved on: 
Thursday, November 5, 2020
Surgery, Kosciusko County, Indiana, Medical specialties, Prosthetics, Economy of Indiana, Knee replacement, Zimmer Biomet, Biomet

The data were presented at the 2020 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS), held November 5-8 in Dallas.

Key Points: 
  • The data were presented at the 2020 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS), held November 5-8 in Dallas.
  • The data presented at the 2020 AAHKS annual meeting evaluated 448 patients who underwent total or partial knee arthroplasty, commonly known as joint replacement.
  • The data poster can be found HERE , and additional information on the mymobility Clinical Study can be found at www.clinicaltrials.gov/ct2/show/NCT03737149 .
  • For more information about the mymobility Clinical Study, visit www.zbmymobility.com
    Founded in 1927 and headquartered inWarsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.

Worldwide Industry for Surgical Staplers to 2025 - Impact of COVID-19

Retrieved on: 
Thursday, November 5, 2020
Fasteners, Stationery, Industrial processes, Surgical staple, Staple, Surgery, Articles, Economy

This report is a professional and in-depth study on the current state of the global Surgical Stapler market with a focus on the Chinese market.

Key Points: 
  • This report is a professional and in-depth study on the current state of the global Surgical Stapler market with a focus on the Chinese market.
  • It is a valuable source of guidance and direction for companies and individuals interested in Surgical Stapler industry.
  • The global Surgical Stapler market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of the 2015-2025 global and Chinese Surgical Stapler market covering all important parameters.

Ocular Therapeutix™ Reports Third Quarter 2020 Financial Results and Business Update

Retrieved on: 
Thursday, November 5, 2020
Research, Surgery, FDA, Clinical trials, Biotechnology, Pharmaceutical, Health, Optical, Science, Other Science, Medical specialties, Clinical medicine, Medicine, Allergic conjunctivitis, Allergology, Conjunctivitis

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the quarter ended September 30, 2020 and provided a business update.

Key Points: 
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the quarter ended September 30, 2020 and provided a business update.
  • It has been a productive quarter for Ocular Therapeutix with a number of key developments that we believe will drive significant long-term value, said Antony Mattessich, President and CEO.
  • Members of the Ocular Therapeutix management team will host a live conference call and webcast today at 4:30 pm Eastern Time to review the Company's financial results and provide a general business update.
  • Ocular Therapeutix recently completed a Phase 3 clinical trial evaluating DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis.